NCX 1102
Latest Information Update: 16 May 2007
Price :
$50 *
At a glance
- Originator NicOx
- Class Antineoplastics; Chemopreventatives; Indenes
- Mechanism of Action Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 02 Sep 2004 Preclinical trials in Cancer and Cancer (Prevention)/Chemoprevention in France (unspecified route)
- 02 Sep 2004 A preclinical study has been added to the Cancer pharmacodynamics section ,
- 01 Oct 2001 Preclinical development for Cancer and Cancer (Prevention)/Chemoprevention in France (Unknown route)